-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Ventyx Biosciences with Buy Rating, Announces Price Target of $20

Benzinga·01/07/2026 20:33:36
Listen to the news
UBS analyst Michael Yee initiates coverage on Ventyx Biosciences (NASDAQ:VTYX) with a Buy rating and announces Price Target of $20.